Tuberculosis, Pulmonary: all 340 studies
Page 4 of 4. Open to participants first (69), then studies with results posted, then the rest; newest registration first within each.
- Replacement of Vitamin D in Patients With Active TuberculosisCompletedNCT01130311Not applicable
- Induced Sputum Versus Bronchoscopy in Smear Negative Pulmonary TuberculosisCompletedNCT01011543Not applicable
- Pharmacokinetic Study of Patients Who Undergo Cycloserine, a 2nd-line Antituberculosis MedicamentCompletedNCT01002170
- Pharmacokinetic Study for Anti-tuberculosis DrugsStatus unknownNCT00948077Not applicable
- The Effectiveness of Health Facility-based and Community-based Care for TuberculosisCompletedNCT00939419Phase 4
- Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary TuberculosisCompletedNCT00933790Phase 3
- Prevalence and Clinical Significance of Co-infection of Mycoplasma Pneumoniae in Patients With Pulmonary TuberculosisStatus unknownNCT00926601
- Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced HepatitisCompletedNCT00834353
- Improving Community Based Tuberculosis Care in EthiopiaCompletedNCT00803322
- Micronutrient Supplementation in in Paediatric Pulmonary TuberculosisCompletedNCT00801606Phase 3
- Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary TuberculosisCompletedNCT00772408
- Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary TuberculosisCompletedNCT00760149Phase 2
- Efficacy of Oral Zinc Administration as an Adjunct Therapy in New Pulmonary Tuberculosis (Category I) PatientsStatus unknownNCT00698386Phase 3
- L-arginine and Vitamin D Adjunctive Therapy in Pulmonary Tuberculosis (TB)CompletedNCT00677339Phase 3
- Rapid Diagnosis of Pulmonary TuberculosisStatus unknownNCT00608790Not applicable
- Isoniazid Dose Adjustment According to NAT2 Genotype (IDANAT2)TerminatedNCT00571753Phase 3
- Co-Infection of NTM in Patients With Smear Positive Pulmonary TBCompletedNCT00567151
- Cytokines and Acute Phase Reactants as Markers of Pulmonary Tuberculosis TreatmentWithdrawnNCT00517231
- Pulmonary Tuberculosis and Vitamin DStatus unknownNCT00507000Phase 3
- MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary TuberculosisCompletedNCT00495339Phase 4
- Trial of Adjunctive Vitamin D in Tuberculosis TreatmentCompletedNCT00419068Phase 3
- A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infectionWithdrawnNCT00414414Phase 3
- Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary TuberculosisCompletedNCT00401271Phase 2
- Pimonidazole Hydrochloride to Detect Low Oxygen in Tuberculosis-Infected LungsWithdrawnNCT00374517Phase 2
- A Clinical Trial to Study the Effect of the Addition of Vitamin D to Conventional Treatment in New Pulmonary Tuberculosis PatientsCompletedNCT00366470Phase 3
- Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.CompletedNCT00341328Phase 3
- Nutrition, Diabetes and Pulmonary TB/HIVCompletedNCT00311298Phase 3
- Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)CompletedNCT00298870Phase 4
- Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment PatientsCompletedNCT00265226Phase 3
- A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary TuberculosisStatus unknownNCT00216385Phase 3
- Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary TuberculosisStatus unknownNCT00216333Phase 4
- Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of MtbCompletedNCT00212550
- TBTC Study 27: Moxifloxacin vs Ethambutol for TB TreatmentCompletedNCT00140309Phase 2
- Vitamin A Therapy for TuberculosisCompletedNCT00057434Phase 3
- Diagnosing Tuberculosis in HIV Infected Children in PeruCompletedNCT00054769
- TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of TuberculosisCompletedNCT00023335Phase 3
- Pilot Randomized Study of Paromomycin (Aminosidine) vs Streptomycin for Uncomplicated Pulmonary TuberculosisCompletedNCT00004444Not applicable
- Interferon Gamma for Drug Resistant TuberculosisCompletedNCT00001407Phase 2
- A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.CompletedNCT00000796Not applicable
- A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and LevofloxacinCompletedNCT00000778Phase 1